Moving toward a process-oriented perspective in the personalized treatment of depression

Eur Arch Psychiatry Clin Neurosci. 2021 Apr;271(3):413-415. doi: 10.1007/s00406-021-01249-9. Epub 2021 Mar 5.

Authors

Johannes Kopf-Beck¹, Julia Fietz^{2

3}

Affiliations

¹ Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Kraepelinstraße 2-10, 80804, Munich, Germany. kopf-beck@psych.mpg.de.
² Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Kraepelinstraße 2-10, 80804, Munich, Germany.
³ International Max Planck Research School for Translational Psychiatry (IMPRS-TP), Munich, Germany.

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antidepressive Agents / pharmacology
Depressive Disorder, Major / drug therapy
Depressive Disorder, Major / physiopathology
Depressive Disorder, Major / therapy*
Humans
Ketamine / pharmacology
Precision Medicine*

Substances

Antidepressive Agents
Esketamine
Ketamine